250 related articles for article (PubMed ID: 26826186)
1. SHIP2 controls plasma membrane PI(4,5)P2 thereby participating in the control of cell migration in 1321 N1 glioblastoma cells.
Elong Edimo W; Ghosh S; Derua R; Janssens V; Waelkens E; Vanderwinden JM; Robe P; Erneux C
J Cell Sci; 2016 Mar; 129(6):1101-14. PubMed ID: 26826186
[TBL] [Abstract][Full Text] [Related]
2. The SHIP2 interactor Myo1c is required for cell migration in 1321 N1 glioblastoma cells.
Edimo WE; Ramos AR; Ghosh S; Vanderwinden JM; Erneux C
Biochem Biophys Res Commun; 2016 Aug; 476(4):508-514. PubMed ID: 27246739
[TBL] [Abstract][Full Text] [Related]
3. Phosphoinositide 5-phosphatase activities control cell motility in glioblastoma: Two phosphoinositides PI(4,5)P2 and PI(3,4)P2 are involved.
Ramos AR; Elong Edimo W; Erneux C
Adv Biol Regul; 2018 Jan; 67():40-48. PubMed ID: 28916189
[TBL] [Abstract][Full Text] [Related]
4. Lipid phosphatases SKIP and SHIP2 regulate fibronectin-dependent cell migration in glioblastoma.
Ramos AR; Ghosh S; Dedobbeleer M; Robe PA; Rogister B; Erneux C
FEBS J; 2019 Mar; 286(6):1120-1135. PubMed ID: 30695232
[TBL] [Abstract][Full Text] [Related]
5. Phosphoinositide 5-phosphatases SKIP and SHIP2 in ruffles, the endoplasmic reticulum and the nucleus: An update.
Ramos AR; Ghosh S; Suhel T; Chevalier C; Obeng EO; Fafilek B; Krejci P; Beck B; Erneux C
Adv Biol Regul; 2020 Jan; 75():100660. PubMed ID: 31628071
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of SHIP2 activity inhibits cell migration and could prevent metastasis in breast cancer cells.
Ghosh S; Scozzaro S; Ramos AR; Delcambre S; Chevalier C; Krejci P; Erneux C
J Cell Sci; 2018 Aug; 131(16):. PubMed ID: 30012834
[TBL] [Abstract][Full Text] [Related]
7. SHIP2 signalling at the plasma membrane, in the nucleus and at focal contacts.
Elong Edimo W; Vanderwinden JM; Erneux C
Adv Biol Regul; 2013 Jan; 53(1):28-37. PubMed ID: 23040614
[TBL] [Abstract][Full Text] [Related]
8. Fibroblasts derived from patients with opsismodysplasia display SHIP2-specific cell migration and adhesion defects.
Ghosh S; Huber C; Siour Q; Sousa SB; Wright M; Cormier-Daire V; Erneux C
Hum Mutat; 2017 Dec; 38(12):1731-1739. PubMed ID: 28869677
[TBL] [Abstract][Full Text] [Related]
9. Lipid phosphatase SHIP2 functions as oncogene in colorectal cancer by regulating PKB activation.
Hoekstra E; Das AM; Willemsen M; Swets M; Kuppen PJ; van der Woude CJ; Bruno MJ; Shah JP; Ten Hagen TL; Chisholm JD; Kerr WG; Peppelenbosch MP; Fuhler GM
Oncotarget; 2016 Nov; 7(45):73525-73540. PubMed ID: 27716613
[TBL] [Abstract][Full Text] [Related]
10. IRSp53 is a novel interactor of SHIP2: A role of the actin binding protein Mena in their cellular localization in breast cancer cells.
Antoine M; Vandenbroere I; Ghosh S; Erneux C; Pirson I
Cell Signal; 2020 Sep; 73():109692. PubMed ID: 32535200
[TBL] [Abstract][Full Text] [Related]
11. Serum withdrawal-induced accumulation of phosphoinositide 3-kinase lipids in differentiating 3T3-L6 myoblasts: distinct roles for Ship2 and PTEN.
Mandl A; Sarkes D; Carricaburu V; Jung V; Rameh L
Mol Cell Biol; 2007 Dec; 27(23):8098-112. PubMed ID: 17893321
[TBL] [Abstract][Full Text] [Related]
12. Differential SKIP expression in PTEN-deficient glioblastoma regulates cellular proliferation and migration.
Davies EM; Kong AM; Tan A; Gurung R; Sriratana A; Bukczynska PE; Ooms LM; McLean CA; Tiganis T; Mitchell CA
Oncogene; 2015 Jul; 34(28):3711-27. PubMed ID: 25241900
[TBL] [Abstract][Full Text] [Related]
13. A new layer of phosphoinositide-mediated allosteric regulation uncovered for SHIP2.
Le Coq J; López Navajas P; Rodrigo Martin B; Alfonso C; Lietha D
FASEB J; 2021 Aug; 35(8):e21815. PubMed ID: 34314064
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of SH2-containing inositol phosphatase 2 results in negative regulation of insulin-induced metabolic actions in 3T3-L1 adipocytes via its 5'-phosphatase catalytic activity.
Wada T; Sasaoka T; Funaki M; Hori H; Murakami S; Ishiki M; Haruta T; Asano T; Ogawa W; Ishihara H; Kobayashi M
Mol Cell Biol; 2001 Mar; 21(5):1633-46. PubMed ID: 11238900
[TBL] [Abstract][Full Text] [Related]
15. IRTKS Promotes Insulin Signaling Transduction through Inhibiting SHIP2 Phosphatase Activity.
Wu C; Cui X; Huang L; Shang X; Wu B; Wang N; He K; Han Z
Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31212584
[TBL] [Abstract][Full Text] [Related]
16. PTEN and Other PtdIns(3,4,5)P
Csolle MP; Ooms LM; Papa A; Mitchell CA
Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33276499
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylated SHIP2 on Y1135 localizes at focal adhesions and at the mitotic spindle in cancer cell lines.
Deneubourg L; Elong Edimo W; Moreau C; Vanderwinden JM; Erneux C
Cell Signal; 2014 Jun; 26(6):1193-203. PubMed ID: 24561238
[TBL] [Abstract][Full Text] [Related]
18. SHIP2 signaling in normal and pathological situations: Its impact on cell proliferation.
Elong Edimo W; Schurmans S; Roger PP; Erneux C
Adv Biol Regul; 2014 Jan; 54():142-51. PubMed ID: 24091101
[TBL] [Abstract][Full Text] [Related]
19. Evidence of SHIP2 Ser132 phosphorylation, its nuclear localization and stability.
Elong Edimo W; Derua R; Janssens V; Nakamura T; Vanderwinden JM; Waelkens E; Erneux C
Biochem J; 2011 Nov; 439(3):391-401. PubMed ID: 21770892
[TBL] [Abstract][Full Text] [Related]
20. The lipid 5-phoshatase SHIP2 controls renal brush border ultrastructure and function by regulating the activation of ERM proteins.
Sayyed SG; Jouret F; Vermeersch M; Pérez-Morga D; Schurmans S
Kidney Int; 2017 Jul; 92(1):125-139. PubMed ID: 28302370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
